Bridging the preclinical gap: High-fidelity data, AI, and the future of sustainable drug discovery
At the recent Global Investment Summit in Paris, key figures across technology, venture capital, and biotechnology gathered at the Palais des Congrès to address one of the most pressing challenges in modern healthcare: how to reshape the funding and development models for transformative cures. Representing Organisyl, Co-founder Abhinav Agarwal joined fellow industry leaders on the